Zdrowie i gospodarka · 22/08/2014
FDA Clears Levoleucovorin Calcium for Approval
The FDA has determined that FUSILEV (levoleucovorin calcium) injection, 175 mg/17.5 mL and 250 mg/25 mL, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.